Table 1.
Target | Drug | Clinical Trials |
---|---|---|
LAG-3 | IMP231 Relatlimab |
NCT00351949 NCT05148546 |
TIM-3 | Sabatolimab INCAGN02390 |
NCT02608268 NCT03652077 |
VISTA | CA-170 | NCT02812875 |
IDO1 | Navoximod | NCT02471846 |
Target | Drug | Clinical Trials |
---|---|---|
LAG-3 | IMP231 Relatlimab |
NCT00351949 NCT05148546 |
TIM-3 | Sabatolimab INCAGN02390 |
NCT02608268 NCT03652077 |
VISTA | CA-170 | NCT02812875 |
IDO1 | Navoximod | NCT02471846 |